Kingdon Capital Management’s Fate Therapeutics FATE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-387,294	Closed	-$1.53M	–	127
2017 Q3	$1.53M	Sell	387,294 -763,653	-66%	-$2.6M	0.12%	101
2017 Q2	$3.73M	Sell	1,150,947 -561,011	-33%	-$2.15M	0.32%	76
2017 Q1	$7.79M	Sell	1,711,958 -903,889	-35%	-$3.31M	0.59%	61
2016 Q4	$6.57M	Sell	2,615,847 -212,042	-7%	-$568K	0.45%	84
2016 Q3	$8.82M	Buy	2,827,889 +569,969	+25%	+$1.38M	0.58%	60
2016 Q2	$3.84M	Hold	2,257,920	–	–	0.31%	81
2016 Q1	$4.06M	Sell	2,257,920 -338,569	-13%	-$697K	0.32%	80
2015 Q4	$8.75M	Buy	2,596,489 +194,265	+8%	+$817K	0.66%	64
2015 Q3	$12.8M	Sell	2,402,224 -5,188	-0.2%	-$35.4K	1.04%	47
2015 Q2	$15.6M	Buy	2,407,412 +884,137	+58%	+$5.29M	0.9%	56
2015 Q1	$7.45M	Sell	1,523,275 -30,900	-2%	-$153K	0.45%	88
2014 Q4	$7.82M	Buy	1,554,175 +126,500	+9%	+$558K	0.42%	83
2014 Q3	$7.28M	Buy	1,427,675 +230,000	+19%	+$1.33M	0.47%	79
2014 Q2	$7.8M	Buy	1,197,675 +84,200	+8%	+$593K	0.41%	94
2014 Q1	$10.5M	Buy	1,113,475 +251,673	+29%	+$1.94M	0.73%	61
2013 Q4	$5.41M	Buy	+861,802	New	+$5.43M	0.38%	116